T cells during acute Epstein-Barr virus infection + The flow cytometric analysis of telomere length in antigen-specific CD8

An activating agent for the treatment of radioactive wastewater. The activating agent is prepared by dissolving a mixture of inorganic salts including Ca2+, Na+, Sr2+, Zn2+, Mg2+, Fe2+ and K+ in pure water having an electrical resistivity greater than 0.5 MΩ·cm to yield a solution. A method of radioactive wastewater treatment using the activating agent includes: 1) preparing the activating agent; 2) adding the activating agent to radioactive wastewater having an electrical resistivity greater than 0.5 MΩ·cm; uniformly mixing the activating agent and the radioactive wastewater; 3) further treating the radioactive wastewater including the activating agent using an electro-deionization device; and 4) collecting two liquid flows obtained in 3), one being purified water, the other being concentrated water returning to 2) for further purification.